Given that women with PCOS have been shown to have a three-fold increased risk of EC compared to women without PCOS [16], direct mitogenic effects [17], elevated bioavailable estrogen levels through a reduction in SHBG levels [18], hyperinsulinemia, and decreased apoptosis have been suggested as potential mechanisms. Here, SHBG is linked to polycystic ovary syndrome.